
STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetes
The FDA has approved a drug that was previously caught in a dispute between career staff and the political appointee head of the CDER.
AI-powered media bias analysis by Daily Composite
Based on analysis of recent Stat News articles using Claude, GPT-4o, Gemini, and Grok. Scores reflect framing and presentation, not factual accuracy.
Learn about our methodology →According to Daily Composite AI analysis of recent Stat News articles, the outlet scores pending — placing it in the Unrated category.
This rating is generated by four independent AI models (Claude, GPT-4o, Gemini, and Grok) analyzing word choice, framing, sources cited, and emotional language in recent articles. The consensus score reduces single-model bias.

The FDA has approved a drug that was previously caught in a dispute between career staff and the political appointee head of the CDER.

The director-general of the World Health Organization is profoundly worried about the Ebola outbreak in the DRC, he told STAT in an interview.

"There are some physicians that work to 100”: Dawn Zuidgeest-Craft on becoming a medical doctor in her 70s.

Trump administration revisits policy to plug Medicare drug price negotiation loophole.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Nonprofit Blood Cancer United acquires cancer drug, Lilly and Nvidia invest in Abridge, and more biotech news

The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta

Kennedy's "publicly" "available" "calendar," drinking during pregnancy, and more health news from Morning Rounds

Hospital execs agree that affordability is a major issue. What to do about it is less clear.

“American science is too valuable to be turned into a political football,” writes David J. Skorton, president of the Association of American Medical Colleges.

“Failing to engage religious and traditional leaders in meaningful ways was a grave misstep in previous Ebola outbreaks,” researchers write.

Many in the diabetes research community expressed shock and disbelief that their colleagues were threatened with arrest for passing out paper copies of an editorial.